Mike Mattie
About Mike Mattie
Mike Mattie serves as the Director of Translational Medicine at Kite Pharma, where he focuses on personalized medicine and translational research. He has a background in molecular toxicology and extensive experience in antibody discovery and genomic technologies.
Work at Kite Pharma
Mike Mattie serves as the Director of Translational Medicine at Kite Pharma, a position he has held since 2018. In this role, he focuses on advancing translational research initiatives and the development of innovative therapies in the field of oncology. His work involves utilizing biomarkers for personalized medicine and supporting various translational research studies. Kite Pharma is known for its commitment to developing cell therapies for cancer treatment, and Mattie's expertise contributes to the company's mission.
Previous Experience at GlaxoSmithKline
Prior to his current role, Mike Mattie worked at GlaxoSmithKline as a Principal Scientist from 2005 to 2011. During his six years there, he contributed to various research projects, leveraging his expertise in molecular biology and translational research. His experience at GlaxoSmithKline helped shape his understanding of drug development processes and the application of scientific research in a corporate setting.
Education and Expertise
Mike Mattie holds a Bachelor of Arts degree in Biology from Claremont McKenna College, where he studied from 1992 to 1996. He furthered his education at Duke University, earning a PhD in Molecular Toxicology from 1998 to 2003. His academic background provides a strong foundation for his expertise in antibody-drug conjugates, bispecifics, and other formats for immune-oncology. He is skilled in various techniques, including phage display, Next-generation sequencing, and microRNA functional genomics.
Background in Laboratory Work
Before his tenure at GlaxoSmithKline, Mike Mattie worked as a Laboratory Technician II at Medtronic from 1996 to 1998. This early experience in a laboratory setting contributed to his technical skills and understanding of laboratory protocols. Additionally, he led the Molecular Engineering group at Agensys, where he focused on antibody discovery and novel antibody formats for immune-oncology, further enhancing his expertise in the field.
Technical Skills and Data Analysis Proficiency
Mike Mattie possesses a wide range of technical skills relevant to his role in translational medicine. He is proficient in data analysis using tools such as JMP, Partek, and ArrayStudio. His experience includes leading the Agensys Integrated Genomics group, where he applied cutting-edge genomics and sequencing technologies to identify novel therapeutic targets. His ability to analyze complex data sets plays a crucial role in advancing research initiatives.